We are live on ! Find out more
AAM

Aureus Asset Management Portfolio holdings

AUM $1.5B
1-Year Est. Return 20.3%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+20.3%
3 Year Est. Return
+80.36%
5 Year Est. Return
+94.66%
10 Year Est. Return
+458.15%
AUM
$279M
AUM Growth
–
Cap. Flow
+$279M
Cap. Flow %
99.71%
Top 10 Hldgs %
25.33%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$8.2M
2
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$8.13M
3
XOM icon
ExxonMobil
XOM
+$7.37M
4
MRK icon
Merck
MRK
+$7.06M
5
MMM icon
3M
MMM
+$6.89M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.84%
2 Healthcare 13.66%
3 Technology 11.58%
4 Financials 10.42%
5 Energy 9.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DALN
101
DELISTED
DallasNews
DALN
$150K 0.05%
+5,475
New +$137K
1 2 3 4
5

Similar funds

TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
JFGLC
Johnson Financial Group LLC (Colorado) Denver, Colorado $1.5B AUM 16.09% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
RCW
Rheos Capital Works Tokyo, Japan $1.5B AUM 47.78% 1-Year Est. Return
SCM
SG Capital Management Chicago, Illinois $1.51B AUM 49.98% 1-Year Est. Return
SGM
Seven Grand Managers Bronxville, New York $1.5B AUM 57.16% 1-Year Est. Return

Aureus Asset Management's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Aureus Asset Management, which disclosed 108 positions worth $279M. Its ten largest holdings account for 25% of the portfolio.

Its largest position is Gilead Sciences: 157,272 shares worth $8.06M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 14% of assets, followed by Healthcare and Technology.

  • Aureus Asset Management's largest Q2 2013 buy was Gilead Sciences: 157,272 shares worth $8.06M.
  • Aureus Asset Management's ten largest holdings make up 25% of its $279M portfolio in Q2 2013.
  • Aureus Asset Management disclosed 108 positions in Q2 2013, its first 13F filing on record.

Based on Aureus Asset Management's 13F filing for Q2 2013, filed 8 Aug 2013.